Pam Thornton
Senior Director of Investor Relations
Replay available
Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Michael Severino
Chief Executive Officer
Dr. Louise Rodino-Klapac
President of R&D and Technical Operations
Patrick Moss
Chief Commercial Officer
Ryan Wong
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Sarepta Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.027 -- 00:00:06.732 Good afternoon and welcome to Sarepta's second quarter 2026 earnings results call. 00:00:06.732 -- 00:00:09.734 As a reminder, today's program is being recorded. 00:00:09.734 -- 00:00:13.917 At this time, I'll turn the call over to Pam Thornton, Sarepta's Senior Director of Investor 00:00:13.917 -- 00:00:17.160 Relations. Please go ahead. 00:00:17.160 -- 00:00:18.241 Thank you. 00:00:18.241 -- 00:00:21.223 And thank you all for joining today's call. 00:00:21.223 -- 00:00:25.286 Earlier this afternoon, we released our financial results for the second quarter of 2026. 00:00:25.286 -- 00:00:30.560 The press release, along with our slides and supplementary information, 00:00:30.560 -- 00:00:33.862 are available on the investor section of our company website. 00:00:33.862 -- 00:00:38.785 We plan to file a Form 10-Q for the quarter today with the SEC. 00:00:38.785 -- 00:00:43.767 Joining me on the call are Michael Severino, our CEO, Dr. 00:00:43.767 -- 00:00:49.110 Louise Rodino-Klapac, President of R&D and Technical Operations, Patrick Moss, 00:00:49.110 -- 00:00:53.953 our Chief Commercial Officer, and Ryan Wong, our Chief Financial Officer. 00:00:53.953 -- 00:00:58.315 Additionally, joining us in the Q&A portion of the call are Ian Estepan, President and 00:00:58.315 -- 00:01:04.594 Chief Operating Officer, and Dr. James Richardson, Chief Medical Officer. 00:01:05.234 -- 00:01:09.075 Before we begin the formal remarks, I would like to note that during this call, we will 00:01:09.075 -- 00:01:11.716 be making a number of forward-looking statements. 00:01:11.716 -- 00:01:15.817 Please refer to slide two of our presentation to view the formal text of these safe harbor 00:01:15.817 -- 00:01:20.758 statements. These statements involve vary...